TuHURA BIOSCIENCES, INC./NV Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price
TuHURA BIOSCIENCES, INC./NV (HURA) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price of $2.17 per share as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice · last filed 2026-08-14
- 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $2.17.
- 2026-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $2.15.
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $2.35.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $5.13.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price |
|---|---|
| 2026-06-30 | $2.17 10-Q · filed 2026-08-14 |
| 2026-03-31 | $2.15 10-Q · filed 2026-05-15 |
| 2025-12-31 | $2.35 10-Q · filed 2026-08-14 |
| 2025-09-30 | $5.13 10-Q · filed 2025-11-14 |
| 2025-06-30 | $5.13 10-Q · filed 2025-08-14 |
| 2025-03-31 | $5.13 10-Q · filed 2025-05-15 |
| 2024-12-31 | $5.11 10-K · filed 2026-03-31 |
| 2023-12-31 | $2.97 10-K · filed 2025-03-31 |
| 2015-06-30 | $0.94 10-K · filed 2015-11-16 |
| 2015-03-31 | $0.94 10-Q · filed 2015-05-15 |
| 2014-03-31 | $0.96 10-Q · filed 2014-05-15 |
| 2013-12-31 | $0.96 10-Q · filed 2014-05-15 |
| 2013-09-30 | $0.97 10-Q · filed 2013-11-08 |
| 2012-12-31 | $0.48 10-Q · filed 2013-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |